课题基金 / 基金详情

项目摘要

项目成果

Charles M Brenner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): RING E3 ubiquitin ligases provide specificity to a huge fraction of biological ubiquitination reactions. Working in a manner that does not involve a covalent intermediate, these molecules bind substrates and specific E2 ubiquitin conjugating enzymes to effect transfer of ubiquitin to Lys residues on substrates, on the E3 (autoubiquitination), and on ubiquitin (polyubiquitination). The distribution, kinetics and specificity of these potentially competing reactions determine whether products will be targeted for proteolysis, differentially localized, and/or signal various forms of stress. We cloned Chfl and Chf2, the yeast homologs of the Chfr tumor suppressor, and developed genetic systems that indicate that Chf-imposed cell cycle delays depend on function of both Ubc4 and Mms2. We reconstituted purified ubiqutination reactions using Ubc4 and Ubc13/Mms2 as the ubiquitin conjugating enzymes and Chf1 and Chf2 as E3 and identified the reaction propecific Aims: 1) We will use quantitative mass spectrometry and enzymology to define the sites, linkages and kinetics of Chf1 and Chf2 ubiquitination reactions with genetically validated ubiquitin conjugating enzymes and the proteins we have identified as Chf interactors. 2) We will determine the sites, linkages, biological consequences, and E2-dependence of Chf1 and Chf2 ubiquitination in vivo. This proposal has two long-term public health objectives. First, determining the mechanisms of function of yeast Chf1 and Chf2 is critical to understand function of Chfr, which is frequently inactivated in human tumors of epithelial origin. Second, innovations in analysis of RING E3 ubiquitin ligases are necessary to understand the specificity of function of RING E3 ubiquitin ligases, which have key functions in the health of every organ system in the human body.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
  • 批准号:
    9765003
  • 项目类别:
  • 资助金额:
    $60.59万
  • 财政年份:
    2019
  • 负责人:
    Charles M Brenner
  • 依托单位:
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
  • 批准号:
    10381462
  • 项目类别:
  • 资助金额:
    $58.26万
  • 财政年份:
    2019
  • 负责人:
    Charles M Brenner
  • 依托单位:
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
  • 批准号:
    9889991
  • 项目类别:
  • 资助金额:
    $59.16万
  • 财政年份:
    2019
  • 负责人:
    Charles M Brenner
  • 依托单位:
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
  • 批准号:
    10671263
  • 项目类别:
  • 资助金额:
    $12.32万
  • 财政年份:
    2019
  • 负责人:
    Charles M Brenner
  • 依托单位:
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: